Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -18,339 | -13,195 | N/A |
| Depreciation Amortization | 358 | 391 | N/A |
| Accounts receivable | -393 | 7 | N/A |
| Other Working Capital | -1,339 | -147 | N/A |
| Other Operating Activity | 4,926 | 3,199 | 0 |
| Operating Cash Flow | $-14,787 | $-9,745 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -141 | -100 | N/A |
| Net Acquisitions | -1,450 | -500 | N/A |
| Investing Cash Flow | $-1,591 | $-600 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 0 | 8,600 | N/A |
| Debt Repayment | -1,156 | -765 | N/A |
| Common Stock Issued | 19 | 17 | N/A |
| Other Financing Activity | 31,251 | -22 | 0 |
| Financing Cash Flow | $30,114 | $7,830 | $N/A |
| Beginning Cash Position | 2,835 | 5,350 | N/A |
| End Cash Position | 16,571 | 2,835 | N/A |
| Net Cash Flow | $13,736 | $-2,515 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -14,787 | -9,745 | N/A |
| Capital Expenditure | -148 | -100 | N/A |
| Free Cash Flow | -14,935 | -9,845 | 0 |